Mister MedTech

Family Offices are the ideal source of capital for MedTech, and we have a full panel at MedTech Malta of Family Offices sharing their reasoning for supporting that statement! MedTech takes a long time and capital needs to be patient. "Patient capital for patient-driven technologies"...now there is a tagline! Huge thanks to Lifeblood's partner and co-host for MedTech Malta, Dylan Attard MD, MRCSI, MEnt. and MedTech World! This panel is wealthy with stories and insights as to how Family Offices are an ideal source of capital for MedTech Startups and companies. A big thank you for coming to Malta for us and looking forward to seeing you on the Mediterranean Rock this week 6-8 November! Moderators: * Giovanni Lauricella, CEO of Lifeblood Panelists: * Steven Levy, Unorthodox Ventures * Pablo Prieto, OG Health Ventures * Sahirzeeshan (Sahir) Ali, Modi Ventures * Dan Jacob Gelvan, t-syte Ltd. * David Prim, PhD, Broadview Ventures Inc With love for being in Malta with MedTech-ers, Giovanni Lauricella CEO of Lifeblood www.lifeblood.com P.S. After Malta this week, you can learn and experience all that Houston has to offer on Monday, November 18th in Houston for the Houston MedTech event. Complimentary registration here: https://lnkd.in/et6Y-Z8q * Sponsor: Goodwin, Lifeblood & Mittal Consulting * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX

Back by popular demand from 2023 is the "Health System Investment Arm" panel at MedTech Malta 2024! This alternative and value-added investor profile for MedTech Startups is one to pay attention to as it has similarities to certain MedTech investment options, yet is completely unique in terms of its value proposition. Find out from these bespoke health systems and investors on how they think about MedTech innovation and support it through capital and resource investments... Check out what happened in 2023 on stage: https://lnkd.in/ef_E4-CE Need an example of how Health System Venture Arms make impactful investments that lead to exits? Ask Liridon Rrushaj from OSF Innovation Ventures on how OSF was one of the first investors into Endotronix that was recently acquired by Edwards Lifesciences: https://lnkd.in/eP6PgsWE Huge thanks to Lifeblood's partner and co-host for MedTech Malta, Dylan Attard MD, MRCSI, MEnt. and MedTech World! This panel is wealthy with stories and insights as to how hospital system venture arms are uniquely positioned within the investor and innovation ecosystem for MedTech and Health Tech! A big thank you for coming to Malta for us and looking forward to seeing you on the Mediterranean Rock this week 6-8 November! Moderators: * Giovanni Lauricella, CEO of Lifeblood * John Sousa, M.D., Senior Recruiter & Medical Officer of Lifeblood Panelists: * John Perez, Rex Health Ventures * Liridon Rrushaj, OSF Innovation and Ventures * Stefan Madansingh, Mayo Clinic Ventures * Todd Schwarzinger, Cleveland Clinic Innovations * Sean J. Cheng, Ascension Ventures With love for being in Malta with MedTech-ers, Giovanni Lauricella CEO of Lifeblood www.lifeblood.com P.S. After Malta this week, you can learn and experience all that Houston has to offer on Monday, November 18th in Houston for the Houston MedTech event. Complimentary registration here: https://lnkd.in/et6Y-Z8q * Sponsor: Goodwin, Lifeblood & Mittal Consulting * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX

Did you ever hear Texas being referred to as "The Third Coast"? This week in Malta we are highlighting Texas' growing MedTech ecosystem and spotlighting the innovation, capital and funding resources, medical centers, talent, strategic geography, and massive market on the panel "Third Coast with First Place Positioning!" Huge thanks to Lifeblood's partner and co-host for MedTech Malta, Dylan Attard MD, MRCSI, MEnt. and MedTech World! This panel is wealthy with stories and insights as to why Texas is strategically positioned both on the map and for its growing success in the MedTech industry. Find out why MedTech in Texas is staying true to the saying, "Everything is bigger in Texas!" A big thank you for coming to Malta for us and looking forward to seeing you on the Mediterranean Rock this week 6-8 November! Moderators: * Giovanni Lauricella, CEO of Lifeblood * John Sousa, M.D., Senior Recruiter & Medical Officer of Lifeblood Panelists: Entrepreneurs * Tushar Sharma, Vivifi Medical * Tyler Melton, Corveus Medical * Werner Vorster, Vitls Inc (Learn about Werner's story of getting to Malta) * Rafael J. Veraza, PhD, MPH, Vascular Perfusion Solutions, Inc. Industry Partners * Alex Condon, Galen Data Academic Research Partners * Savannah Esteve Morreale, MD Anderson Cancer Center With love for being in Malta with MedTech-ers, Giovanni Lauricella CEO of Lifeblood www.lifeblood.com P.S. After Malta this week, you can learn and experience all that Houston has to offer on Monday, November 18th in Houston for the Houston MedTech event. Complimentary registration here: https://lnkd.in/et6Y-Z8q * Sponsor: Goodwin, Lifeblood & Mittal Consulting * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX

"Why Houston MedTech?" is a special panel assembled for MedTech Malta to highlight Houston, Texas's importance in the MedTech industry, and to get the word out there that Houston has the largest medical center in the world enabling access to patients for clinical trials and world class facilities! MedTech Startups can literally be initiated, developed, clinically validated, and commercialized from Houston. Don't believe me? Ask Albert Huang, MD who started, developed, commercialized, and exited Allotrope Medical in 2023 all from Houston, Texas! This panel is wealthy with stories and insights as to what Houston as to offer and also the inertia that it has as a developing community for medical innovation. For Houston, the time is now! A big thank you for coming to Malta for us and looking forward to seeing you on the Mediterranean Rock this week 6-8 November! Moderators: * Giovanni Lauricella, CEO of Lifeblood * John Sousa, M.D., Senior Recruiter & Medical Officer of Lifeblood Panelists: Entrepreneurs * Albert Huang, MD, Allotrope Medical * Meagan R. Pitcher, Ph.D., Bairitone Health * 🦸♀️ Swarna Balasubramaniam, MD, Noleus Technologies Investors * Bob Shaw, Houston Angel Network Physicians * Justin Bird, MD Anderson Cancer Center Academic Research Partners * Homer Quintana, Houston Methodist With love for being in Malta with MedTech-ers, Giovanni Lauricella CEO of Lifeblood www.lifeblood.com P.S. After Malta this week, you can learn and experience all that Houston has to offer on Monday, November 18th in Houston for the Houston MedTech event. Complimentary registration here: https://lnkd.in/et6Y-Z8q * Sponsor: Goodwin, Lifeblood & Mittal Consulting * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX

"The MedTech Startup Equation" is about bringing together the numerous stakeholder perspectives on what it takes to build a MedTech company. Entrepreneurs, investors, physicians, corporate strategics, and industry partners come together to discuss how they contribute to building businesses and commercializing medical technologies. This panel is wealthy with stories of building MedTech companies from their own perspectives and will have the punch line as to why it takes a village of stakeholders to develop and commercialize medical technologies! A big thank you for coming to Malta for us and looking forward to seeing you on the Mediterranean Rock 6-8 November...THAT'S NEXT WEEK! Moderators: * Giovanni Lauricella, CEO of Lifeblood * Malek Nasr, Co-Founder of HighLife Panelists: Entrepreneurs * Anna Lisa Somera, CEO of Rhaeos Investors * Sanchita Pasi, Investor at EQT Life Sciences * Rik Vandevenne, Managing Director at RC Capital Corporate Strategics * Howard Hechler, President of Lumicell * David McDonough, President at Northgate Technologies Inc. Physicians * Austin Lee Chiang, MD MPH, Chief Medical Officer at Medtronic Endoscopy Industry Partners * Nathan Piland, M.Eng, MBA, Founder of Nunex With love for being in Malta with MedTech-ers, Giovanni Lauricella CEO of Lifeblood www.lifeblood.com

"Serial Entrepreneurship in MedTech: Why We Continue?" Some call MedTech..."HardTech." And building one MedTech Startup is hard enough...these entrepreneurs keep doing it over and over. I want to find out why these entrepreneurs aren't on a beach sippin' margaritas or left the industry to go build a winery or jumped into crypto...and why they continue to build MedTech Startups. If you want a sneak peak into what Daniel Hawkins's theory is, check out this MedTech Money podcast that we did together in 2021...and he still keeps going: https://lnkd.in/eG6us_P4 This panel is wealthy with stories of building MedTech companies and will have the punch line as to why they continue to endure the game of "HardTech." A big thank you for coming to Malta for us and looking forward to seeing you on the Mediterranean Rock 6-8 November...THAT'S NEXT WEEK! Moderators: * Giovanni Lauricella, CEO of Lifeblood * Joseph Snyder, Principal of Lifeblood Panelists: * Daniel Hawkins, CEO of Vista.ai * Amir Gross, CEO of Cardiovalve * Youssef Biadillah, CEO of BariaTek * Tyler Wanke, CEO of Madison Scientific Inc * Anna Lisa Somera, CEO of Rhaeos With love for being in Malta with MedTech-ers, Giovanni Lauricella CEO of Lifeblood www.lifeblood.com

U.S. Chief Commercialization Officer (CCO) Opportunity: This European, vascular, MedTech Startup has closed $50M in financing and is launching in The United States of America 🇺🇸. This CCO will be “THE FACE” of this company in the U.S. market and representing the European HQ! This video is live from the Washington Monument in DC during TCT as we gear up for “MedTech Malta” 🇲🇹 next week, which is taking place 6-8 November 2024 https://lnkd.in/excrRfQ6 On Monday, November 18th we are hosting Houston MedTech in the Texas Medical Center. Complimentary registration for this investor, strategic, and entrepreneur event is here https://lnkd.in/et6Y-Z8q Lifeblood is retained on this U.S. Chief Commercialization Opportunity that has multiple products launching in the market after raising a total of $50 million to-date. This European company is 100% focused on the largest market in the 🌎 and building its commercial team to execute a competitive product launch! What we need is a strategic commercial executive that is capable of designing the commercial strategy in parallel of regulatory clearance, building the commercial team, and enabling the commercial launch and story to resonate with the Board of Directors and future cross-over investors. Think of the commercial leaders for companies like Penumbra, Inc., Cardiovascular Systems, Inc., Shockwave Medical, Abiomed, Silk Road Medical, Inc., etc that built up meaningful commercial execution that enabled the company to exit (IPO or acquisition)…that’s the DNA 🧬 of profile that we need for this CCO. To save time…here are the minimum keys 🔑 to unlock 🔓 a conversation to learn more about this opportunity (see below). If you reach out and don’t hear back it’s because your key wasn’t working. Minimum experience… * Based in the U.S. * Vascular device commercialization experience * Capable of being the first commercial hire that can design, set, and execute the strategy for a product’s market entry and launch * Experience pitching commercial strategies to investors and boards of directors * Able to work in a MedTech Startup with limited resources and a fast paced environment - while reporting to the European HQ When you think of a U.S. CCO for a vascular company that can develop “the” commercial plan and execute on the market launch, who comes to mind? That’s who this position is for. Reach out to Giovanni Lauricella at giovanni@lifeblood.com to learn more… With love for building European startup teams launching in the U.S, Giovanni Lauricella of Lifeblood The MedTech Industry's Global Recruitment and Advisory Firm www.lifeblood.com

VP of Clinical Affairs Opportunity: This BCI (Brain-Computer Interface) company has raised ~$100M worth of believers for the development of this generational technology that is at the crossroads of classically defined “medical devices,” deeptech, and human augmentation. This is a true “executive” position that is reporting to the CEO, presenting to the board of directors, and building a sizable team. This position will be a “Face” for the BCI industry to the FDA, the company, and our future as humans. Check out these articles and videos on BCI companies like Motif Neurotech (Houston shout out!), Blackrock Neurotech, INBRAIN Neuroelectronics, Neuralink, Paradromics Inc., Nia Therapeutics, Cognixion, etc. https://lnkd.in/eajPg9vU https://lnkd.in/e2cx3Sk4 https://lnkd.in/ePXCV7XS https://lnkd.in/eF7Jbw7q Lifeblood is retained on this U.S. Vice President of Clinical Affairs that will be tasked with designing and executing multiple clinical trials for arguably the most challenging medical device in human history. There is no such thing as a perfect candidate with relevant experience of getting a BCI through regulatory approval from achieving excellent clinical data from the design and execution of clinical trials. Why? BECAUSE THIS HAS NEVER BEEN DONE BEFORE! What we need is a polished clinical affairs professional who wants to take on the future, has experience with designing complex clinical trials for Class III electromechanical implantable medical devices, and isn’t afraid of being outward facing and reporting to an intense board of directors. To save time…here are the minimum keys 🔑 to unlock 🔓 a conversation to learn more about this opportunity (see below). If you reach out and don’t hear back it’s because your key wasn’t working. Minimum experience… * Based in the U.S. * Corporate MedTech experience * Ability to build and lead large teams * Experience with executing clinical trials for electromechanical medical device that have longterm patient follow up * Ability to travel 50% or more * Excellent oral and written communication and presentation skills When you think of a U.S. Vice President of Clinical Affairs that is capable of this much polish, industry exposure, and experience with complex devices and trials…that’s who we are looking for! Heck, think about the caliber of clinical affairs professional who has risen to CEO or GM like Lisa Wipperman Heine, Kate Rumrill or Tara Dunn! Reach out to Giovanni Lauricella at giovanni@lifeblood.com to learn more… With love for recruiting clinical affairs executives tasked with changing the future of humans, Giovanni Lauricella of Lifeblood The MedTech Industry's Global Recruitment and Advisory Firm www.lifeblood.com